Your browser doesn't support javascript.
Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses.
Lin, Pin-Hung; Liang, Chieh-Yu; Yao, Bing-Yu; Chen, Hui-Wen; Pan, Ching-Fu; Wu, Li-Ling; Lin, Yi-Hsuan; Hsu, Yu-Sung; Liu, Yu-Han; Chen, Pei-Jer; Hu, Che-Ming Jack; Yang, Hung-Chih.
  • Lin PH; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Liang CY; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Yao BY; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
  • Chen HW; Department of Veterinary Medicine, National Taiwan University, Taipei, Taiwan.
  • Pan CF; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Wu LL; Institute of Physiology, National Yang-Ming Chiao-Tung University, Taipei City, Taiwan.
  • Lin YH; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsu YS; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Liu YH; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
  • Chen PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Yang HC; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Mol Ther Methods Clin Dev ; 21: 299-314, 2021 Jun 11.
Article in English | MEDLINE | ID: covidwho-1144097
ABSTRACT
Antigen-specific lung-resident memorycells (TRMs) constitute the first line of defense that mediates rapid protection against respiratory pathogens and inspires novel vaccine designs against infectious pandemic threats, yet effective means of inducing TRMs, particularly via non-viral vectors, remain challenging. Here, we demonstrate safe and potent induction of lung-resident TRMs using a biodegradable polymeric nanoshell that co-encapsulates antigenic peptides and TLR9 agonist CpG-oligodeoxynucleotide (CpG-ODN) in a virus-mimicking structure. Through subcutaneous priming and intranasal boosting, the combinatorial nanoshell vaccine elicits prominent lung-resident CD4+ and CD8+ T cells that surprisingly show better durability than live viral infections. In particular, nanoshells containing CpG-ODN and a pair of conserved class I and II major histocompatibility complex-restricted influenza nucleoprotein-derived antigenic peptides are demonstrated to induce near-sterilizing immunity against lethal infections with influenza A viruses of different strains and subtypes in mice, resulting in rapid elimination of replicating viruses. We further examine the pulmonary transport dynamic and optimal composition of the nanoshell vaccine conducive for robust TRM induction as well as the benefit of subcutaneous priming on TRM replenishment. The study presents a practical vaccination strategy for inducing protective TRM-mediated immunity, offering a compelling platform and critical insights in the ongoing quest toward a broadly protective vaccine against universal influenza as well as other respiratory pathogens.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Randomized controlled trials Topics: Vaccines Language: English Journal: Mol Ther Methods Clin Dev Year: 2021 Document Type: Article Affiliation country: J.omtm.2021.03.010

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Randomized controlled trials Topics: Vaccines Language: English Journal: Mol Ther Methods Clin Dev Year: 2021 Document Type: Article Affiliation country: J.omtm.2021.03.010